Aires HRV and Cardiovascular Research: Results and Limitations

Heart rate variability (HRV) describes variation in the intervals between heartbeats. It depends on measurement conditions and physiology. A favorable-looking HRV change or a device-generated “stress” score alone does not demonstrate improved cardiovascular health.

Lifetune ONE: HRV comparisons were nonsignificant

The 2024 report lists LF/HF changes from 1.6 ± 0.8 to 1.2 ± 0.6 without the device, and from 1.5 ± 0.4 to 0.8 ± 0.7 with it. The comparisons were not statistically significant. The device-associated direction interested the authors, but the data do not support the earlier “p<0.05 normalization” claim. LF/HF should not be interpreted as a simple diagnostic meter of sympathetic versus parasympathetic health.

Study summary and sample-size notes · Original report (PDF).

Havas: pulse-wave observations in two people

The two 2015 reports describe selected favorable MaxPulse indices, mixed results in other indices, little HRV change and no improvement in heart rate or blood pressure. Each participant had a fixed sequence of conditions. These findings justify investigation; they do not establish a general cardiovascular benefit or a reproducible treatment effect.

First case summary · First original report · Second case summary · Second original report.

Datova: before-and-after observations

The 2013 report studied 13 volunteers without a sham or time/rest control. Several reported indices improved, but some table labels and denominators require clarification. Software-derived functional scores are not equivalent to clinical diagnoses or proven disease-risk reduction.

Read Datova’s report (PDF).

Publication and review labels

The reports above are not all journal clinical trials. PACE means the Planetary Association for Clean Energy. A PACE expert opinion is a distinct document type; it should not be labeled journal peer review or United Nations approval of a product.

Additional records in this topic

These links preserve access to related and historical summaries. Their source documents, study versions and endpoint claims are being reconciled individually. Inclusion here does not establish independent replication or verify every claim in an older summary. The Sysoev and Rybina manuscript is a version of the experiment discussed above.

• Sysoev and Rybina: related manuscript version guide
• Datova: 2013 HRV summary
• Kuznetsova: 2020 ECG/HRV record

Sources and disclosure

This is an Aires editorial summary. Aires sells the products discussed and has a commercial interest in the research. Institutional affiliation, an external author, or a third-party opinion alone does not establish financial independence. Where a linked report does not establish funding or the sponsor’s role, those details remain unconfirmed. Original researchers retain authorship of their work.

The original-source evidence library distinguishes journal articles, conference papers, research reports and expert opinions. Reports, translations and later manuscripts describing the same experiment should not be counted as independent replications.

Editorial update: October 25, 2026 · Josh, Aires. This page explains research and its limitations; it is not a diagnosis or a claim that an Aires product prevents or treats disease.